Lowlite Investments, Inc. (dba Olympia Pharmacy)
FDA inspection history in Orlando, Florida, 2013 to 2026
- 6
- Form 483s
Every document, by year
- Form 483
2013: one Form 483; 2018: one Form 483; 2022: one Form 483; 2024: one Form 483; 2025: one Form 483; 2026: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2013One Form 483, at Orlando, Florida.
- 2018One Form 483, at Orlando, Florida.
- 2022–26Four Form 483s, at Orlando, Florida.
- 2022The longest 483 on file: 13 observations over 20 pages at Orlando, Florida.
Cited most
Across all Lowlite Investments, Inc. (dba Olympia Pharmacy) observations on file
- 21 CFR 211.42Design and construction features13
- 21 CFR 211.113Control of microbiological contamination7
- 21 CFR 211.100Written procedures; deviations4
- 21 CFR 211.165Testing and release for distribution3
- 21 CFR 211.166Stability testing3
The complete Lowlite Investments, Inc. (dba Olympia Pharmacy) file.
All 6 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
15% off buying them one by one
Sites
Orlando, Florida
Six Form 483s · 2013 to 2026 · 52 observations
Latest: Form 483, Sep 3, 2026 →
Documents
6 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2026-09-03 | 483 Form 483 | Orlando, Florida | 8 | $99 |
| 2025-08-08 | 483 Form 483 | Orlando, Florida | 2 | $99 |
| 2024-05-29 | 483 Form 483 | Orlando, Florida | 7 | $99 |
| 2022-03-02 | 483 Form 483 | Orlando, Florida | 13 | $99 |
| 2018-04-13 | 483 Form 483 | Orlando, Florida | 10 | $99 |
| 2013-03-21 | 483 Form 483 | Orlando, Florida | 12 | $99 |
Investigators on these documents
Jessica P. McAlister (2)Camerson E. Moore (1)Caryn M. McNab (1)Clinton J. Lott (1)Joanne E. King (1)Jose R. Lopez (1)Kayla V. Sprague (1)Libia M. Lugo (1)Logan T. Williams (1)Michelle Lin (1)Mindy M. Chou (1)Brooke K. Higgins (1)
FEI number 3009724085 · most recent document Sep 3, 2026
About Lowlite Investments, Inc. (dba Olympia Pharmacy)
How many FDA Form 483s has Lowlite Investments, Inc. (dba Olympia Pharmacy) received?
FDA Intel has 6 Form 483s on file for Lowlite Investments, Inc. (dba Olympia Pharmacy); the most recent is dated Sep 3, 2026.
When was Lowlite Investments, Inc. (dba Olympia Pharmacy) last inspected by FDA?
The most recent FDA inspection document on file for Lowlite Investments, Inc. (dba Olympia Pharmacy) is a Form 483 dated Sep 3, 2026, for the site in Orlando, Florida.
What did FDA cite at Lowlite Investments, Inc. (dba Olympia Pharmacy)?
The regulations cited most in the observations on file for Lowlite Investments, Inc. (dba Olympia Pharmacy) are 21 CFR 211.42 (Design and construction features), 13 times; 21 CFR 211.113 (Control of microbiological contamination), 7 times; 21 CFR 211.100 (Written procedures; deviations), 4 times.